Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 13
2018 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Future Oncol"
Page 1
Diagnosis and Treatment of Aplastic Anemia.
Peslak SA, Olson T, Babushok DV. Peslak SA, et al. Curr Treat Options Oncol. 2017 Nov 16;18(12):70. doi: 10.1007/s11864-017-0511-z. Curr Treat Options Oncol. 2017. PMID: 29143887 Free PMC article. Review.
With the recent appreciation of frequent clonal hematopoiesis in AA patients and with the growing use of next-generation sequencing in the clinic, utmost caution should be exercised in interpreting the significance of somatic mutations in AA. Future longitudinal studies of …
With the recent appreciation of frequent clonal hematopoiesis in AA patients and with the growing use of next-generation sequencing in the c …
Bile Acids and Cancer: Direct and Environmental-Dependent Effects.
Di Ciaula A, Wang DQ, Molina-Molina E, Lunardi Baccetto R, Calamita G, Palmieri VO, Portincasa P. Di Ciaula A, et al. Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s87-s105. doi: 10.5604/01.3001.0010.5501. Ann Hepatol. 2017. PMID: 29080344 Free article. Review.
Primary prevention strategies (i.e. changes in dietary habits and lifestyle, reduced exposure to environmental toxics) mainly able to modulate gut microbiota and the epigenome, and the therapeutic use of hydrophilic BAs to counterbalance the negative effects of the more hydrophob …
Primary prevention strategies (i.e. changes in dietary habits and lifestyle, reduced exposure to environmental toxics) mainly able to modula …
Personalizing Radiation Treatment Delivery in the Management of Breast Cancer.
Ahmed KA, Grass GD, Orman AG, Liveringhouse C, Montejo ME, Soliman HH, Han HS, Czerniecki BJ, Torres-Roca JF, Diaz R. Ahmed KA, et al. Int J Breast Cancer. 2018 Jun 10;2018:6729802. doi: 10.1155/2018/6729802. eCollection 2018. Int J Breast Cancer. 2018. PMID: 29984003 Free PMC article. Review.
In this review, we discuss our efforts to personalize radiotherapy dosing using genomic data and the implications for future clinical trials. We also explore immune mechanisms that may contribute to a tumor's unique radiation sensitivity or resistance....
In this review, we discuss our efforts to personalize radiotherapy dosing using genomic data and the implications for future clinical …
Axicabtagene ciloleucel for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphomas.
Sharma P, King GT, Shinde SS, Purev E, Jimeno A. Sharma P, et al. Drugs Today (Barc). 2018 Mar;54(3):187-198. doi: 10.1358/dot.2018.54.3.2776625. Drugs Today (Barc). 2018. PMID: 29771253 Review.
In this review we will discuss the mechanism of action of axi-cel, clinical trials leading to its FDA approval, ongoing clinical trials and its potential adverse effects, and will speculate on the future directions of axi-cel and CAR T-cell therapy in general....
In this review we will discuss the mechanism of action of axi-cel, clinical trials leading to its FDA approval, ongoing clinical trials and …
New Approaches in CAR-T Cell Immunotherapy for Breast Cancer.
Wang J, Zhou P. Wang J, et al. Adv Exp Med Biol. 2017;1026:371-381. doi: 10.1007/978-981-10-6020-5_17. Adv Exp Med Biol. 2017. PMID: 29282693 Review.
Then we discuss the barriers of solid tumors for CARs application and possible strategies to improve therapeutic response with a focus on breast cancer. At last, we outlook the future directions of CAR-T therapy including managing toxicities and developing universal CAR-T …
Then we discuss the barriers of solid tumors for CARs application and possible strategies to improve therapeutic response with a focus on br …
Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors.
Askoxylakis V, Arvanitis CD, Wong CSF, Ferraro GB, Jain RK. Askoxylakis V, et al. Adv Drug Deliv Rev. 2017 Sep 15;119:159-174. doi: 10.1016/j.addr.2017.06.011. Epub 2017 Jun 22. Adv Drug Deliv Rev. 2017. PMID: 28648712 Review.
., focused ultrasound) to modulate the blood-tumor-barrier, along with limitations of each approach. Finally, we offer some new avenues of future research....
., focused ultrasound) to modulate the blood-tumor-barrier, along with limitations of each approach. Finally, we offer some new avenues of …
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.
Käsmann L, Niyazi M, Blanck O, Baues C, Baumann R, Dobiasch S, Eze C, Fleischmann D, Gauer T, Giordano FA, Goy Y, Hausmann J, Henkenberens C, Kaul D, Klook L, Krug D, Mäurer M, Panje CM, Rosenbrock J, Sautter L, Schmitt D, Süß C, Thieme AH, Trommer-Nestler M, Ziegler S, Ebert N, Medenwald D, Ostheimer C; Young DEGRO Trial Group. Käsmann L, et al. Strahlenther Onkol. 2018 Feb;194(2):79-90. doi: 10.1007/s00066-017-1221-y. Epub 2017 Oct 13. Strahlenther Onkol. 2018. PMID: 29030654 Review. English.
Several potential confounding variables were found and need to be considered for future studies to evaluate GTV changes during definitive radiotherapy with respect to treatment outcome....
Several potential confounding variables were found and need to be considered for future studies to evaluate GTV changes during defini …
Patient reported outcome measures in breast cancer patients.
Lagendijk M, van Egdom LSE, Richel C, van Leeuwen N, Verhoef C, Lingsma HF, Koppert LB. Lagendijk M, et al. Eur J Surg Oncol. 2018 Jul;44(7):963-968. doi: 10.1016/j.ejso.2018.03.009. Epub 2018 Mar 21. Eur J Surg Oncol. 2018. PMID: 29678302
Ninety-four percent of the participants was (highly) satisfied with future PROM use. CONCLUSIONS: Statistical significant differences were found for PROMs following different types of breast surgery. The significance of these results should become clearer trough collection …
Ninety-four percent of the participants was (highly) satisfied with future PROM use. CONCLUSIONS: Statistical significant differences …
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
Kanis JA, Cooper C, Rizzoli R, Abrahamsen B, Al-Daghri NM, Brandi ML, Cannata-Andia J, Cortet B, Dimai HP, Ferrari S, Hadji P, Harvey NC, Kraenzlin M, Kurth A, McCloskey E, Minisola S, Thomas T, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Kanis JA, et al. Osteoporos Int. 2017 Jul;28(7):2023-2034. doi: 10.1007/s00198-017-4009-0. Epub 2017 Apr 27. Osteoporos Int. 2017. PMID: 28451733 Free PMC article.
Identification of patients who are at particularly high risk will help clinicians target appropriate treatment more precisely and cost-effectively, and should be the focus of future research. INTRODUCTION: The purpose of the study was to review data on the identification a …
Identification of patients who are at particularly high risk will help clinicians target appropriate treatment more precisely and cost-effec …
Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.
Qian Y, Zhu H, Pollom EL, Durkee BY, Chaudhuri AA, Gensheimer MF, Diehn M, Shultz DB, Loo BW Jr. Qian Y, et al. Pract Radiat Oncol. 2017 Nov-Dec;7(6):e525-e529. doi: 10.1016/j.prro.2017.04.005. Epub 2017 Apr 13. Pract Radiat Oncol. 2017. PMID: 28669706
CONCLUSION: While uncommon, SAN toxicity from SABR to right-sided central thoracic tumors should be recognized and followed in future studies....
CONCLUSION: While uncommon, SAN toxicity from SABR to right-sided central thoracic tumors should be recognized and followed in future …
19 results